Business Description
Ensol Biosciences Inc
ISIN : KR7140610007
Compare
Compare
Traded in other countries / regions
140610.Korea IPO Date
2018-09-10Description
Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.52 | |||||
Equity-to-Asset | -0.58 | |||||
Debt-to-Equity | -1.57 | |||||
Debt-to-EBITDA | -0.89 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -12.61 | |||||
Beneish M-Score | -3.17 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37.6 | |||||
3-Year EBITDA Growth Rate | 6.8 | |||||
3-Year EPS without NRI Growth Rate | -4 | |||||
3-Year FCF Growth Rate | -7 | |||||
3-Year Book Growth Rate | -15.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.14 | |||||
9-Day RSI | 48.59 | |||||
14-Day RSI | 52.98 | |||||
6-1 Month Momentum % | 30.8 | |||||
12-1 Month Momentum % | -50.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.38 | |||||
Quick Ratio | 0.38 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 2183.94 | |||||
Days Sales Outstanding | 92.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.6 | |||||
Shareholder Yield % | -8.2 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.25 | |||||
Operating Margin % | -5421.39 | |||||
Net Margin % | -6401.82 | |||||
FCF Margin % | -4648.12 | |||||
ROA % | -100.37 | |||||
ROIC % | -50.37 | |||||
ROC (Joel Greenblatt) % | -230.12 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 369.9 | |||||
EV-to-EBIT | -6.89 | |||||
EV-to-EBITDA | -7.3 | |||||
EV-to-Revenue | 396.52 | |||||
EV-to-FCF | -9.32 | |||||
Earnings Yield (Greenblatt) % | -14.51 | |||||
FCF Yield % | -12.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ensol Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 176.545 | ||
EPS (TTM) (â‚©) | -1054 | ||
Beta | 0.91 | ||
Volatility % | 81.11 | ||
14-Day RSI | 52.98 | ||
14-Day ATR (â‚©) | 572.257906 | ||
20-Day SMA (â‚©) | 6150 | ||
12-1 Month Momentum % | -50.83 | ||
52-Week Range (â‚©) | 2800 - 13900 | ||
Shares Outstanding (Mil) | 10.83 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ensol Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ensol Biosciences Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Ensol Biosciences Inc Frequently Asked Questions
What is Ensol Biosciences Inc(XKRX:140610)'s stock price today?
The current price of XKRX:140610 is â‚©6120.00. The 52 week high of XKRX:140610 is â‚©13900.00 and 52 week low is â‚©2800.00.
When is next earnings date of Ensol Biosciences Inc(XKRX:140610)?
The next earnings date of Ensol Biosciences Inc(XKRX:140610) is .
Does Ensol Biosciences Inc(XKRX:140610) pay dividends? If so, how much?
Ensol Biosciences Inc(XKRX:140610) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |